Home > Resources > Company Profiles > Illumina Incorporated

Illumina Incorporated (ILMN)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Jay T. Flatley , CEO/President/Director

www.illumina.com

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

The Company is developer, manufacturer and marketer of integrated systems for the analysis of genetic variation and biological function.

News Feeds

Out of the Gate: Illumina sets all-time high AP
Jul 23 2008
Outlook roundup: Illumina, Edwards Lifesciences AP
Jul 22 2008
Illumina board approves 2-for-1 stock split AP
Jul 22 2008
Illumina buys company for $25 million upfront AP
Jul 22 2008
Illumina boosts 2008 profit and revenue outlook AP
Jul 22 2008
Illumina's 2Q profit surges on sales boost AP
Jul 22 2008
Illumina shares hit new all-time high AP
Jul 02 2008
Illumina president and CEO sells shares AP
Jul 01 2008

Press Releases

Illumina Reports Financial Results for Second Quarter 2008 Jul-22-2008, 04:01PM EDT
Illumina Appoints Stephen Pentoney as Vice President of Array Biochemistry Jul-21-2008, 06:30AM EDT
Illumina to Announce Second Quarter 2008 Financial Results on Tuesday, July 22, 2008 Jul-08-2008, 06:00AM EDT
The Wellcome Trust Case Control Consortium (WTCCC) Selects Illumina Infinium High-Density (HD) DNA Analysis Products to Study 90,000 Samples Jul-01-2008, 06:00AM EDT
Illumina Appoints Fredrick Clerie as Vice President of Quality Assurance and Regulatory Affairs Jun-23-2008, 06:00AM EDT

News From Around the Web

News

Out of the Gate: Illumina sets all-time high (Boston Globe)

Jul 23 2008
Healthcare Companies that Start with the Letter "I" Outperform (iStockAnalyst)

Jul 23 2008
Illumini, Intuitive: This Healthcare Outperformance Brought to You by the Letter 'I' (SeekingAlpha)

Jul 23 2008
Outlook roundup: Illumina, Edwards Lifesciences (Boston Globe)

Jul 22 2008
Illumina's 2Q profit surges on sales boost (Boston Globe)

Jul 22 2008
Illumina buys company for $25 million upfront (Boston Globe)

Jul 22 2008
Illumina board approves 2-for-1 stock split (Businessweek)

Jul 22 2008
Illumina Inc. Is Rising After Q2 Report (RTTNews)

Jul 22 2008

Employees

Number of Employees: 1,041

Revenue per Employee: $527,903

Top Executives

Christian G. Cabou, General Counsel/Senior VP/Secretary

Tristan B. Orpin, Senior VP, Divisional

John R. Stuelpnagel, D.V.M., Founder/Senior VP/COO/General Manager, Divisional

Christian O. Henry, CFO/Senior VP/General Manager, Divisional

Board of Directors

Roy A. Whitfield, Director

Dr. David R. Walt, Ph.D., Founder/Director

Christian G. Cabou, General Counsel/Senior VP/Secretary

Dr. Jack Goldstein, Ph.D., Director

Dr. Paul Grint M.D., Director

John R. Stuelpnagel, D.V.M., Founder/Senior VP/COO/General Manager, Divisional

Karin Eastham, Director

A. Blaine Bowman, Director

Dr. William H. Rastetter, Ph.D., Director/Chairman of the Board

Daniel M. Bradbury, Director

Financials

Quarterly

Annual

Income Statement	04/2008	02/2008	10/2007	07/2007
Sales	48.5 Mil.	40.76 Mil.	34.03 Mil.	26.87 Mil.
Gross Operating Profit	73.36 Mil.	71.84 Mil.	63.48 Mil.	57.67 Mil.
Operating Income before D & A (EBITDA)	18.97 Mil.	21.78 Mil.	19.42 Mil.	16.19 Mil.
Total Income Before Interest Expenses (EBIT)	22.55 Mil.	25.15 Mil.	19.69 Mil.	14.59 Mil.
Total Net Income	13.43 Mil.	-4.05 Mil.	14.5 Mil.	9.26 Mil.
Basic EPS, Total	0.24	-0.07	0.27	0.17
Diluted EPS, Total	0.21	-0.07	0.24	0.16

BALANCE STATEMENT	04/2008	02/2008	10/2007	07/2007
Cash and Equivalents	118.61 Mil.	174.94 Mil.	64.11 Mil.	81.12 Mil.
Total Assets	464.66 Mil.	562.76 Mil.	486.93 Mil.	452.19 Mil.
Total Liabilities	469.52 Mil.	165.72 Mil.	79.02 Mil.	76.61 Mil.
Total Capitalization	451.09 Mil.	811.68 Mil.	721.26 Mil.	686.84 Mil.

Cash Flow	04/2008	02/2008	10/2007	07/2007
Net Cash From Continuing Operations	-62.76 Mil.	56.02 Mil.	44.44 Mil.	39.13 Mil.
Net Cash From Investing Activities	-8.12 Mil.	-67.69 Mil.	-136.07 Mil.	-103.92 Mil.
Net Cash From Financing Activities	15.98 Mil.	148.57 Mil.	117.85 Mil.	107.42 Mil.
Net Change in Cash & Cash Equivalents	-56.33 Mil.	136.56 Mil.	25.72 Mil.	42.73 Mil.

Income Statement	2008	2007	2006	2005
Sales	134.86 Mil.	53.64 Mil.	19.45 Mil.	9.1 Mil.
Gross Operating Profit	231.93 Mil.	130.95 Mil.	54.05 Mil.	41.48 Mil.
Operating Income before D & A (EBITDA)	56.74 Mil.	43.52 Mil.	-1.65 Mil.	-4.72 Mil.
Total Income Before Interest Expenses (EBIT)	-288.78 Mil.	43.18 Mil.	-20.04 Mil.	-4.57 Mil.
Total Net Income	-278.36 Mil.	39.97 Mil.	-20.87 Mil.	-6.22 Mil.
Basic EPS, Total	-5.14	0.9	-0.52	-0.17
Diluted EPS, Total	-5.14	0.82	-0.52	-0.17

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	174.94 Mil.	38.39 Mil.	50.82 Mil.	54.79 Mil.
Total Assets	562.76 Mil.	193.73 Mil.	79.71 Mil.	83.69 Mil.
Total Liabilities	165.72 Mil.	33.78 Mil.	21.72 Mil.	19.05 Mil.
Total Capitalization	811.68 Mil.	247.34 Mil.	72.55 Mil.	72.26 Mil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	56.02 Mil.	39 Mil.	-9.01 Mil.	-19.57 Mil.
Net Cash From Investing Activities	-67.69 Mil.	-160.74 Mil.	-1.54 Mil.	57.02 Mil.
Net Cash From Financing Activities	148.57 Mil.	109.3 Mil.	5.96 Mil.	4.88 Mil.
Net Change in Cash & Cash Equivalents	136.56 Mil.	-12.44 Mil.	-3.97 Mil.	42.32 Mil.

Illumina Incorporated (ILMN)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request